Tocilizumab in the treatment of myocardial infarction-Reference-Cited by-同舟云学术

Tocilizumab in the treatment of myocardial infarction

Published:2018-01-30 Issue:5 Volume:28 Page:733-735
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Carroll Matthew B.¹

Affiliation:

1. Rheumatology, Keesler Medical Center, Keesler AFB, Biloxi, MS, USA

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14397595.2018.1427457

Reference25 articles.

1. Genentech website.[Internet] Genentech US Drug Safety, 1 DNA Way, Mailstop 258A, South San Francisco, CA 94080. Available from: https://www.gene.com/media/press-releases/14679/2017-08-30/fda-approves-genentechs-actemra-tocilizumab [last accessed 30 Sept 2017].

2. Multicentric Castleman’s disease associated with IgA vasculitis (Henoch-Schönlein purpura) responding well to tocilizumab: a case report

3. Discovery of Innovative Therapies for Rare Immune-Mediated Inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman’s Disease

4. Short-term efficacy of the IL6 receptor antibody tocilizumab in patients with HIV-associated multicentric Castleman disease: report of two cases

5. Successful treatment by tocilizumab without steroid in a very severe case of TAFRO syndrome

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis reveals inhibition of the inflammatory cytokine IL-6 affords limited protection post-myocardial ischemia/infarction;Heliyon;2022-08

2. Impact of Age on Systemic Inflammatory Profile of Patients With ST-Segment–Elevation Myocardial Infarction and Acute Ischemic Stroke;Stroke;2022-07

3. Investigating the predictive value of microRNA21 as a biomarker in induced myocardial infarction animal model;Gene Reports;2022-06

4. Inflammation and ischemic heart disease: The next therapeutic target?;Revista Portuguesa de Cardiologia;2021-10

5. Inflammation and ischemic heart disease: The next therapeutic target?;Revista Portuguesa de Cardiologia (English Edition);2021-10